These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 412968)

  • 41. NMR and mass spectrometric characterization of vinblastine, vincristine and some new related impurities - part I.
    Dubrovay Z; Háda V; Béni Z; Szántay C
    J Pharm Biomed Anal; 2013 Oct; 84():293-308. PubMed ID: 22985529
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative effects of vincristine and vindesine on cell cycle kinetics in vitro.
    Hill BT; Whelan RD
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():5-15. PubMed ID: 6159973
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastine.
    Beck WT; Cirtain MC; Glover CJ; Felsted RL; Safa AR
    Biochem Biophys Res Commun; 1988 Jun; 153(3):959-66. PubMed ID: 2898941
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antitumor and toxic effects of amotin].
    Sedakova LA; Bukharova IK; Treshchalin ID; Syrkin AB
    Eksp Onkol; 1987; 9(5):76-7. PubMed ID: 3691399
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cellular uptake and tubulin binding properties of four Vinca alkaloids.
    Singer WD; Himes RH
    Biochem Pharmacol; 1992 Feb; 43(3):545-51. PubMed ID: 1540212
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo and in vitro pharmacokinetics and metabolism of vincaalkaloids in rat. I. Vindesine (4-deacetyl-vinblastine 3-carboxyamide).
    Rahmani R; Zhou XJ; Placidi M; Martin M; Cano JP
    Eur J Drug Metab Pharmacokinet; 1990; 15(1):49-55. PubMed ID: 2384117
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NMR and mass spectrometric characterization of vinblastine, vincristine and some new related impurities--part II.
    Háda V; Dubrovay Z; Lakó-Futó A; Galambos J; Gulyás Z; Aranyi A; Szántay C
    J Pharm Biomed Anal; 2013 Oct; 84():309-22. PubMed ID: 23177164
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigation of the in vivo anti-invasive and anti-metastatic effect of desacetyl vinblastine amide sulphate or vindesine.
    Atassi G; Dumont P; Vandendris M
    Invasion Metastasis; 1982; 2(4):217-31. PubMed ID: 7188395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of murine CFU-C by vindesine: restoration of colony growth by colony stimulating factor.
    Pigoli G; Mangoni L; Caramatti C; Degliantoni G; Rizzoli V
    Int J Cell Cloning; 1983 Jul; 1(3):142-50. PubMed ID: 6609213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative pharmacokinetics of vindesine, vincristine and vinblastine in patients with cancer.
    Nelson RL; Dyke RW; Root MA
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():17-24. PubMed ID: 7438117
    [No Abstract]   [Full Text] [Related]  

  • 51. Cellular pharmacokinetics of vinblastine and other vinca alkaloids in MO4 cells.
    Van Belle SJ; De Smet MC; De Mey JE; Storme GA
    Anticancer Res; 1991; 11(1):465-71. PubMed ID: 2018383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radioimmunoassay and preliminary pharmacokinetic studies in rats of 5'-noranhydrovinblastine (navelbine).
    Rahmani R; Martin M; Barbet J; Cano JP
    Cancer Res; 1984 Dec; 44(12 Pt 1):5609-13. PubMed ID: 6498821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A 125I-radiolabelled probe for vinblastine and vindesine radioimmunoassays: applications to measurements of vindesine plasma levels in man after intravenous injections and long-term infusions.
    Rahmani R; Barbet J; Cano JP
    Clin Chim Acta; 1983 Mar; 129(1):57-69. PubMed ID: 6851151
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vindesine. A short review of preclinical and first clinical data.
    Dyke RW; Nelson RL; Brade WP
    Cancer Chemother Pharmacol; 1979; 2(4):229-32. PubMed ID: 455579
    [No Abstract]   [Full Text] [Related]  

  • 55. High-performance liquid chromatographic determination of vinblastine, 4-O-deacetylvinblastine and the potential metabolite 4-O-deacetylvinblastine-3-oic acid in biological fluids.
    van Tellingen O; Beijnen JH; Baurain R; ten Bokkel Huinink WW; van der Woude HR; Nooyen WJ
    J Chromatogr; 1991 Aug; 553(1-2):47-53. PubMed ID: 1787167
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enzymology of indole alkaloid biosynthesis in Catharanthus roseus.
    Misra N; Luthra R; Kumar S
    Indian J Biochem Biophys; 1996 Aug; 33(4):261-73. PubMed ID: 8936815
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biochemical effects of vindesine.
    Creasey WA
    Br J Cancer; 1981 Dec; 44(6):921-4. PubMed ID: 7326201
    [No Abstract]   [Full Text] [Related]  

  • 58. Biodegradation of the antineoplastics vindesine, vincristine, and vinblastine and their toxicity against bacteria in the aquatic environment.
    Al-Ahmad A; Kümmerer K
    Cancer Detect Prev; 2001; 25(1):102-7. PubMed ID: 11270417
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential involvement of glutathione S-transferase mu 1 and multidrug resistance protein 1 in melanoma acquired resistance to vinca alkaloids.
    Attaoua C; Vincent LA; Abdel Jaoued A; Hadj-Kaddour K; Baï Q; De Vos J; Vian L; Cuq P
    Fundam Clin Pharmacol; 2015 Feb; 29(1):62-71. PubMed ID: 25283245
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of in vitro and in vivo effects of vincristine and vindesine on leukemic cells from patients with chronic granulocytic leukemia in blast crisis.
    Theodorakis ME; Goldberg J
    Leuk Res; 1984; 8(6):1065-71. PubMed ID: 6595480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.